Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
5
×
deals
5
×
life sciences
national blog main
clinical trials
national top stories
boston
fda
startups
alexion pharmaceuticals
alnylam pharmaceuticals
autoimmune disorders
glaxosmithkline
hepatitis b
investing
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
4d molecular therapeutics
abbvie
acne
agenus
allosteric
amyotrophic lateral sclerosis (als)
astrazeneca
atlas venture
atopic dermatitis
auris health
avexis
bayer
beijing
biomx
bladder cancer
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
brace pharma
brii bio
What
disease
5
×
drug
medicines
adds
hepatitis
new
pharma
pharmaceuticals
potential
address
ago
alliance
allosteric
alternative
approved
areas
autoimmune
bio
biosciences
bio’s
brii
candidate
caught
causing
clinic
companies
deal
dicerna
digital
earlier
elusive
epidemic
expensive
eye
fatty
fda
frenzied
gene
growing
hotspot
Language
unset
Current search:
biotech
×
disease
×
deals
×
" boston top stories "
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline